GILEAD SCIENCES, INC. portfolio

Latest available portfolio: Q2 2026 · Holdings as of 30 Jun 2026 · Filed 03 Aug 2026 ·

$1.65B

Full value: $1,648,747,919 · USD · 30 Jun 2026

in Form 13F holdings

Quarterly portfolio filings

Choose a quarter to see holdings and changes. Newer portfolio dates appear first.

Estimated additions and reductions value share changes at filing-derived prices; they are not actual trade proceeds or costs.

Quarter	Holdings	SEC-reported value	Est. additions	Est. reductions	Est. net	Top Holdings	Form Type	Accepted by SEC
Q2 2026	5	$1,648,747,919	+$12,962,261	-$771,682,600	-$758,720,339	RCUS, LKFT, ASMB, KYTX, XLO	13F-HR	03 Aug 2026, 16:37
Q1 2026	6	$2,117,784,504	$0	-$71,107,065	-$71,107,065	ACLX, RCUS, GLPG, ASMB, KYTX	13F-HR	08 May 2026, 17:00
Q4 2025	6	$1,935,507,854	$0	-$85,797,631	-$85,797,631	RCUS, GLPG, ACLX, ASMB, KYTX	13F-HR	12 Feb 2026, 16:36
Q3 2025	9	$1,791,467,184	+$58,775,552	-$5,069,444	+$53,706,108	GLPG, ACLX, RCUS, ASMB, MRUS	13F-HR	13 Nov 2025, 16:44
Q2 2025	14	$1,280,204,668	$0	-$2,420,378	-$2,420,378	GLPG, ACLX, RCUS, ASMB, TNGX	13F-HR	14 Aug 2025, 10:58
Q1 2025	14	$1,181,331,731	+$16,512,425	-$9,131,340	+$7,381,085	ACLX, GLPG, RCUS, ASMB, MRUS	13F-HR	13 May 2025, 16:15
Q4 2024	16	$1,551,148,266	$0	$0	$0	ACLX, GLPG, RCUS, ASMB, MRUS	13F-HR	13 Feb 2025, 16:14

Showing 1-7 of 7 filings.

Manager details and filing context

Latest 13F filing: Q2 2026 - 03 Aug 2026
Latest reported 13F value: $1,648,747,919
Largest 13F holdings: RCUS LKFT ASMB KYTX XLO
Form 13F summary: GILEAD SCIENCES, INC. Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
Form 13F is generally due within 45 days after each calendar quarter ends.
GILEAD SCIENCES, INC. reported 5 equity holdings with a total reported market value of $1,648,747,919 for Q2 2026. Top reported holdings included RCUS, LKFT, ASMB, KYTX, and XLO.
Manager signature: Andrew D. Dickinson - Executive Vice President and Chief Financial Officer
Manager location: Foster City, CA

Holdings Value